VERICI DX PLC (VRCI) — Investor Presentation

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the VERICI DX PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions could be submitted at any time by the q and a tab situated on the right hand corner of your screen. Simply type in your question and press send. Company may not be in a position to answer every question received during the meeting itself. Have a review of all questions submitted today and publish responses where it's appropriate to do so. Before we begin, we'd like to submit the following poll. Now I'd like to hand you over to Sarah Barrington, CA. Good afternoon. Good afternoon. Thanks for having me. Did you say you're next to a poll? That's already gone out there, Sarah. Great. That's fine. Just second. Then we can get started. So welcome, everybody. This is just a strategic update. And, obviously, off the back of last week's announcements, I'm sure there's quite a lot of interest in understanding a little bit more about that announcement. What we'll do in this presentation is we've got a number of, if you like, notes refresher for anybody that that that would like that. I will be quick through that so that it won't dominate the whole presentation. We will then talk obviously, there's a number of other updates that I think it's worth just mentioning. Then, obviously, we'll finish on the Thermo deal and then take q and a afterwards. Okay. Just to give an overview of the company, obviously, we are a kidney diagnostic kidney transplant diagnostics company. We do have an offering of three clinical products, and then we have our Asperc as as almost a data science company. We we have a full product in terms of what we call the research asset, and we'll be giving an update on all of those. Into kidney transplants d...